Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.
The Nutshell
Daily News Roundup
Most Recent
A human trial of a hepatitis C treatment is shut down after one of the participants died.
Another person has died from the rodent-borne disease after visiting Yosemite National Park.
The California legislature takes steps to broaden the ability of graduate students to unionize by extending collective bargaining rights to research assistants.
Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.
The presumed vice-presidential candidate gets a mixed review on science funding and attitudes.
A polar bear in a German zoo dies after contracting a virus normally found in zebras.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
The presidential bioethics brain trust unveils its draft recommendations on the use of whole genome sequencing in clinical care and research.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
